1. Григорян О.Р., Андреева Е.Н. Менопаузальный синдром у женщин с нарушениями углеводного обмена. Альтернативные и дополнительные методы терапии в климактерии (обзор литературы) // Гинекология. 2011. (3). 4–7.
2. Дедов И.И., Шестакова М.В. (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. М., 2011.
3. Рожинская Л.Я. Системный остеопороз. Практич. рук-во для врачей. М., 2000. 196 с.
4. Руяткина Л.А., Бондарева З.Г., Федорова Е.Л. и др. Гормонпродуцирующая функция яичников у женщин молодого и среднего возраста с артериальной гипертензией и ИБС // Клинич. мед. 2005. (2). 40–44.
5. Шишкова В.Н. Ожирение и остеопороз // Остеопороз и остеопатии. 2011. (1). 21–26.
6. Carey D.G., Jenkins A.B., Campbell L.V. et al. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM // Diabetes. 1996. 45. (5). 633–638.
7. Cutrim D.M., Pereira F.A., de Paula F.J., Foss M.C. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes melli tus // Braz. J. Med. Biol. Res. 2007. 40. (2). 221–227.
8. Gerdhem P., Akesson K. Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study // J. Bone Joint Surg. Br. 2007. 89. (12). 1627–1631.
9. Gilsanz V., Chalfant J., Mo A.O. et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength // J. Clin. Endocrinol. Metab. 2009. 94. (9). 3387–3393.
10. Janghorbani M., Van Dam R.M., Willett W.C. et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture // Am. J. Epidemiol. 2007. 166. (5). 495–505.
11. Kahn S.E., Zinman B., Lachin J.M. et al. Diabetes Outcome Progression Trial (ADOPT) Study Group. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT) // Diabetes Care. 2008. 31. (5). 845–851.
12. Kiel D.P., Kauppila L.I., Cupples L.A. et al. Bone loss and the progression of abdominal aortic calcification over a 25-year period: the Framingham heart study // Calcif. Tissue Int. 2001. 68. 271–276.
13. Lieben L., Callewaert F., Bouillon R. Bone and metabolism: a complex crosstalk // Horm. Res. 2009.
71. (Suppl. 1). 134–138
14. Monami M., Dicembrini I., Antenore A., Mannucci E. Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-anlysis of randomized clinical trials // Diabetes Care. 2011. 34. (11). 2474–2476.
15. Muscogiuri G., Sorice G.P., Prioletta A. et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity // Obesity (Silver Spring). 2010. 18. (10). 1906–1910.
16. Nicodemus K.K., Folsom A.R. Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women // Diabetes Care. 2001. 24. (7). 1192–1197.
17. Poehlman E.T., Tchernof A. Traversing the menopause: changes in energy expenditure and body composition // Coronary Artery Dis. 1998. 9. 799–803.
18. Premaor M.O., Pilbrow L., Tonkin C. et al. Obesity and fractures in postmenopausal women // J. Bone Mineral Res. 2010. 25. (2). 292–297.
19. Simkin-Silverman L.R., Wing R.R., Boraz M.A. et al. Maintenance of cardiovascular risk factor changes among middle-aged women in a lifestyle intervention trial // Womens Health. 1998. 4. (3). 255–271.
20. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes – a meta-analysis // Osteoporos Int. 2007. 18. (4). 427–444.
21. Yamaguchi T., Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus // Endocr. J. 2011. 58. (8). 613–624.